DRW Securities’s Revelation Biosciences REVB Stock Holding History

DRW Securities’s Portfolio REVB Stock Details REVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,318	Closed	-$110K	–	1616
2025 Q3	$110K	Buy	+19,318	New	+$188K	﹤0.01%	1173

Other funds holding REVB

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

DRW Securities's REVB Position: Q4 2025 in Review

DRW Securities sold out of Revelation Biosciences (REVB) in Q4 2025, closing a stake of 19,318 shares — an estimated $110K sold.

DRW Securities first reported a position in REVB in Q3 2025 and held it in 1 quarter. The position peaked at $110K in Q3 2025. 13 funds tracked by Wall St. Rank hold REVB as of Q4 2025.

DRW Securities reported no remaining Revelation Biosciences position as of Q4 2025 after selling out during the quarter.
DRW Securities sold 19,318 Revelation Biosciences shares in Q4 2025, an estimated $110K.
DRW Securities first reported a position in Revelation Biosciences in Q3 2025 and held it in 1 quarter.
DRW Securities's Revelation Biosciences position peaked at $110K in Q3 2025.
13 funds tracked by Wall St. Rank held Revelation Biosciences as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.